ECO Animal Health Group plc
ECO Animal Health Group plc, established in 1972 and based in New Malden, United Kingdom, focuses on the worldwide research, regulatory approval, and distribution of veterinary pharmaceutical solutions. The company's offerings include Aivlosin, a macrolide antibiotic specifically formulated to address digestive and…
1D
+0.5%
1W
-1.6%
1M
-0.5%
6M
-5.5%
YTD
-10.0%
1Y
+17.5%
2Y
+27.0%
5Y
-67.3%
10Y
-81.0%
Next earnings date
No date known
Volatility around earnings
~130% stronger price swings than usual
P/E
29.1
P/B
0.73
EV/EBITDA
5.03
RETURN ON EQUITY
2.9%
NET MARGIN
5.3%
DEBT/EQUITY
0.06
DIVIDEND YIELD
0.0%
AS OF
31/03/2026
FREE FLOAT
88.8%
FLOAT SHARES
59,271,417
AVG. DAILY VOLUME (30D)
192,930
ECO Animal Health Group plc is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United Kingdom.
The CEO is David Charles Hallas, the company employs around 213 people.
The IPO was on 26/09/1995; the stock trades on LSE under the ticker EAH.L.
Around past earnings, price swings were roughly 130% stronger than usual.
Yes. The last dividend was £1.00 per share, ex-date 23/09/2021, paid on 22/10/2021.
The dividend yield is 0.0% (as of 31/03/2026).
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess ECO Animal Health Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.